Found 172 results
Author Title [ Type(Asc)] Year
Filters: First Letter Of Title is R  [Clear All Filters]
Journal Article
J. Romero, Cohen, A., Boron, M., and Rankin, M., RSV Prophylaxis in Minority Populations; Results from the Palivizumab Outcomes Registry 2002-2003, Pediatric Research, vol. 55, p. 237A, 2004.
A. Gelfand, Cohen, A., Boron, M., Rankin, M., and Group, theSynagis Ou, RSV prophylaxis in African American children; results from the Palivizumab outcomes registry, 2004.
A. Gelfand, Cohen, A., Boron, M., Rankin, M., and Group, theSynagis Ou, RSV prophylaxis in African American children; results from the Palivizumab outcomes registry, Am J Resp Crit Care Med, vol. 169, 2004.
A. Gelfand, Cohen, A., Boron, M., Rankin, M., and Group, theSynagis Ou, RSV prophylaxis in African American children; results from the Palivizumab outcomes registry, 2004.
A. Gelfand, Cohen, A., Boron, M., Rankin, M., and Group, T. Synagis®, RSV prophylaxis in 60 children with cystic fibrosis; results from the “Real World” experience - Palivizumab Outcomes Registry, 2004.
C. Nerwen, Frogel, M. P., Hirsch, R. L., Boron, M. L., Van Veldhuisen, P. C., and Registry, S. ®Outcomes, RSV Hospitalization and prophylaxis: Influence of Baseline Demographics and Risk Factors on Outcomes in the 2001-2002 Synagis® Outcomes Registry, Pediatric Research, vol. 53, p. 231A, 2003.
C. Nerwen, Frogel, M. P., Hirsch, R. L., Boron, M. L., Van Veldhuisen, P. C., and Registry, S. Outcomes, RSV Hospitalization and prophylaxis: Influence of baseline demographics and risk factors on outcomes in the 2001-2002 Synagis® Outcomes Registry, 2003.
T. L. Jensen, Frasketi, M., Conway, K., Villarroel, L., Hill, H., Krampis, K., and Goll, J. B., RSEQREP: RNA-Seq Reports, an open-source cloud-enabled framework for reproducible RNA-Seq data processing, analysis, and result reporting., F1000Res, vol. 6, p. 2162, 2018.
R. E. McClead, McGregor, M. L., Bremer, D., Cole, C., Fellows, R., Phelps, D., and Oden, N., ROP Outcome in Infants with Prethreshold ROP and SpO2 ›94% in Room Air, 2000.
A. S. Lindblad, The Role of Macular Pigment Density Measures in Future Clinical Studies of Age-Related Macular Degeneration, JAMA Ophthalmol, 2017.
F. Curro, Craig, R., Vena, D., and Thompson, V., The Role of Interim Analysis as a Quality Assurance Function in Practice-Based Research Network Clinical Studies, Compend Contin Educ Dent, vol. 30, pp. 352-354, 2009.
B. J. Vena D, The risk of secondary malignancies following purine analog therapy of chronic lymphocytic leukemia (CLL) and hairy cell leukemia (HCL)., Proc ASCO., p. 52, 1997.
J. Burch, Mair, D., Meny, G., Moroff, G., Ching, S., Naidoff, M., Steuer, E., Loftus, S., Armstrong, J., Clemons, T., and Klein, B., The Risk of Posterior Subcapsular Cataracts in Granulocyte Donors, Transfusion, vol. 45, pp. 1701-1708, 2005.
E. Chew, Sperduto, R., Milton, R., Clemons, T., Gensler, G., Bressler, S., Klein, R., Klein, B., Ferris, F. 3rd, and Group, A. R. E. D. S. Study, Risk of Advanced Age-Related Macular Degeneration after Cataract Surgery in the Age-Related Eye Disease Study: AREDS Report No. 25, Ophthalmology, vol. 116, pp. 297-303, 2009.
M. Atkinson, Martz, K., Warady, B., and Neu, A. M., Risk for Anemia in Pediatric Chronic Kidney Disease Patients: A Report of NAPRTCS, Pediatric Nephrology, vol. 25, no. 9, pp. 1699-1706, 2010.
S. D, Risk factors for vascular thrombosis (VT) in pediatric renal transplantation,, 1996.
S. D, Risk factors for vascular thrombosis (VT) in pediatric renal transplantation,, 1996.
S. DM, Risk factors for vascular thrombosis in pediatric renal transplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study,, Transplantation., vol. 63, pp. 1263-67, 1997.
T. E. Clemons, Klein, B. E. K., and Sperduto, R. D., Risk factors for the progression of lens opacities in the Age-Related Eye Disease Study (AREDS), 2004.
R. W. Shepherd, Turmelle, Y., Nadler, M., Lowell, J. A., Narkewicz, M. R., McDiarmid, S. V., Anand, R., and Song, C., Risk factors for rejection and infection in pediatric liver transplantation., Am J Transplant, vol. 8, no. 2, pp. 396-403, 2008.
E. M, Risk factors for preeclampsia in healthy nulliparous women,, 1997.
M. Ewell, Risk factors for preeclampsia in healthy nulliparous women., Am J Obstet Gynecol, vol. 177, pp. 1003-10, 1997.
V. R. Dharnidharka, Sullivan, E. K., Stablein, D. M., Tejani, A. H., and Harmon, W. E., Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS), Transplantation, vol. 71, pp. 1065-8, 2001.
V. R. Dharnidharka, Sullivan, E. K., Tejani, A. H., and Harmon, W. E., Risk factors for post transplant lymphoproliferative disorder (PTLD): An analysis of the cases in the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS), 1999.
A. Barasch, Cunha-Cruz, J., Curro, F., Hujoel, P., Sung, A., Vena, D., Voinea-Griffin, A., Beadnell, S., Craig, R., DeRouen, T., Desaranayake, A., Gilbert, A., Gilbert, G., Goldberg, K., Hauley, R., Hashimoto, M., Holmes, J., Latzke, B., Leroux, B., Lindblad, A., and Richman, J., Risk Factors for Osteonecrosis of the Jaws: A Case-Control Study from the CONDOR Dental PBRN, J Dent Res, vol. 90, pp. 439-444, 2011.